Our Research

Our lab uses chemical approaches to control cellular systems as exemplified by the development of Proteolysis Targeting Chimeras (PROTACs) in the new field of Targeted Protein Degradation


Craig is awarded the 2021 Scheele Prize from the Swedish Pharmaceutical Society

Professor Craig Crews has been awarded the Scheele prize 2021 for his broad excellence in drug discovery and development spanning from molecule to patient. He has combined groundbreaking science with strong entrepreneurship and received wide international recognition for his work on pharmacological modulation of protein turnover. His findings have led to new therapeutic approaches including the development of novel proteasome inhibitors and the PROTAC technology.

Read more >